Megyn Kelly Slams Oprah's 'Obesity Gene' as GLP-1 Cop-Out

Conservative podcaster Megyn Kelly criticized Oprah Winfrey for remarks linking overeating to an "obesity gene" in a new book on obesity and GLP-1 medications.

Oprah Winfrey's Take on Obesity and GLP-1

Oprah Winfrey collaborated with endocrinologist Dr. Ania Jastreboff on Enough: Your Health, Your Weight and What It's Like to Be Free, released January 13 by Avid Reader Press. Winfrey shared her weight loss journey, crediting GLP-1 drugs for quieting constant "food noise"—an urge to eat.

On The View, Winfrey stated: "I understand that if you carry the obesity gene, if that is what you have, that is what makes you overeat. You don't overeat and become obese. Obesity causes you to overeat." She described food noise as a lifelong challenge for those with obesity.

Megyn Kelly's Response: A 'Cop-Out'?

In her January 16 podcast episode, Kelly discussed Winfrey's comments with journalist Maureen Callahan. Kelly said: "I do like I have nothing against the GLP-1s, but I do think this like, 'It's a disease and I had no personal responsibility in my morbidly obese body' is a cop-out."

Kelly countered that food thoughts are human: "It's called being human... We all love it. You eat out of boredom. I mean, millions of Americans who have never been obese have that food conversation in their head, but they managed to say no."

Debate on Personal Responsibility and Side Effects

Callahan noted Winfrey's past claims of her weight struggles being uniquely exploited. She called it Winfrey's "favorite narrative." Both raised questions about GLP-1 drugs, with Callahan citing reports of severe side effects from users.

• Callahan reviewed the book: Winfrey contributed a short foreword, while Dr. Jastreboff wrote most of it.
• Kelly viewed the book as another publicity move.

Winfrey promoted the book and her shifted obesity views, including a January 13 podcast with Serena Williams discussing GLP-1 medications.

Key Implications for Weight Management

The exchange highlights tensions between genetic factors, GLP-1 therapies, and discipline in weight management. While Winfrey emphasizes biology and drug benefits, critics stress behavioral control.